Tags

Type your tag names separated by a space and hit enter

Studies in otitis media: Children's Hospital of Pittsburgh-University of Pittsburgh progress report--2004.
Laryngoscope. 2004 Nov; 114(11 Pt 3 Suppl 105):1-26.L

Abstract

OBJECTIVES/HYPOTHESIS

The present Progress Report has summarized the key otitis media clinical trials and laboratory studies conducted since 1969 by investigators at the Children's Hospital of Pittsburgh-University of Pittsburgh (Pittsburgh, PA).

STUDY DESIGN

Review.

METHODS

Included in the discussion are the following: 1) studies of the epidemiology and risk factors; 2) anatomy and pathology of the eustachian tube-middle ear from human temporal bone histopathological specimens; 3) physiology and pathophysiology of the eustachian tube-middle ear in humans and animal models; 4) pathogenesis; 5) otitis media in special populations (e.g., patients with cleft palate, Native Americans, patients with Down syndrome); 6) microbiology; 7) diagnosis; 8) outcomes of randomized clinical trials that evaluated efficacy of nonsurgical and surgical methods of treatment and prevention; 9) studies of certain complications and sequelae (e.g., effect of middle-ear effusion on hearing, early child development, and the vestibular system; chronic suppurative otitis media). Also included are relevant summary tables and 256 references.

Authors+Show Affiliations

Department of Pediatric Otolaryngology, University of Pittsburgh School of Medicine-Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15514559

Citation

Bluestone, Charles D.. "Studies in Otitis Media: Children's Hospital of Pittsburgh-University of Pittsburgh Progress Report--2004." The Laryngoscope, vol. 114, no. 11 Pt 3 Suppl 105, 2004, pp. 1-26.
Bluestone CD. Studies in otitis media: Children's Hospital of Pittsburgh-University of Pittsburgh progress report--2004. Laryngoscope. 2004;114(11 Pt 3 Suppl 105):1-26.
Bluestone, C. D. (2004). Studies in otitis media: Children's Hospital of Pittsburgh-University of Pittsburgh progress report--2004. The Laryngoscope, 114(11 Pt 3 Suppl 105), 1-26.
Bluestone CD. Studies in Otitis Media: Children's Hospital of Pittsburgh-University of Pittsburgh Progress Report--2004. Laryngoscope. 2004;114(11 Pt 3 Suppl 105):1-26. PubMed PMID: 15514559.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Studies in otitis media: Children's Hospital of Pittsburgh-University of Pittsburgh progress report--2004. A1 - Bluestone,Charles D, PY - 2004/10/30/pubmed PY - 2004/12/23/medline PY - 2004/10/30/entrez SP - 1 EP - 26 JF - The Laryngoscope JO - Laryngoscope VL - 114 IS - 11 Pt 3 Suppl 105 N2 - OBJECTIVES/HYPOTHESIS: The present Progress Report has summarized the key otitis media clinical trials and laboratory studies conducted since 1969 by investigators at the Children's Hospital of Pittsburgh-University of Pittsburgh (Pittsburgh, PA). STUDY DESIGN: Review. METHODS: Included in the discussion are the following: 1) studies of the epidemiology and risk factors; 2) anatomy and pathology of the eustachian tube-middle ear from human temporal bone histopathological specimens; 3) physiology and pathophysiology of the eustachian tube-middle ear in humans and animal models; 4) pathogenesis; 5) otitis media in special populations (e.g., patients with cleft palate, Native Americans, patients with Down syndrome); 6) microbiology; 7) diagnosis; 8) outcomes of randomized clinical trials that evaluated efficacy of nonsurgical and surgical methods of treatment and prevention; 9) studies of certain complications and sequelae (e.g., effect of middle-ear effusion on hearing, early child development, and the vestibular system; chronic suppurative otitis media). Also included are relevant summary tables and 256 references. SN - 0023-852X UR - https://www.unboundmedicine.com/medline/citation/15514559/Studies_in_otitis_media:_Children's_Hospital_of_Pittsburgh_University_of_Pittsburgh_progress_report__2004_ L2 - https://doi.org/10.1097/01.mlg.0000148223.45374.ec DB - PRIME DP - Unbound Medicine ER -